Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

计划入组 18 人 · 首次发布于 2013 年 1 月 11 日

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

计划入组 70 人 · 首次发布于 2022 年 4 月 8 日

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

计划入组 71 人 · 首次发布于 2014 年 6 月 11 日

GL-0001

GL-0719

GL-522

UNIVERSITY OF CHESTER

United Kingdom

FemTec Health, Inc.

United States

Wacker Chemie Ag

Norway

GL CHEMTEC Completes State-of-the-Art GMP Facility to Accelerate Clinical Trial Material Production

Agora Open Science Trust Selects M4K2009 as Lead Candidate for Rare Pediatric Brain Cancer Treatment

Genetic Leap Receives FDA IND Clearance for First-in-Class Oral IL-2 Modulator GL-IL2-138